ROYCE & ASSOCIATES LP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2013$540,000
-0.6%
4,600
-11.5%
0.00%0.0%
Q3 2013$543,000
-89.0%
5,200
-91.0%
0.00%
-86.7%
Q2 2013$4,955,00057,5680.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders